This study identified that in cases of metastatic disease, Korean urologist’s preference for ADT at a university hospital was CAB rather than GnRH agonist monotherapy for improving overall survival, as well as palliation4, 5, 6. The gene discussed is GNRH1; the disease is metastatic neoplasm.